Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Achim Heinecke

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Inflammatory Bowel Diseases|June 15, 2007
Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in lifeBarbara Sonntag, Birgit Stolze, Achim Heinecke, et al.
Thrombosis and Haemostasis|May 12, 2005
Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control studyManuela Krause, Barbara Sonntag, Robert Klamroth, et al.
Circulation|August 27, 2003
Cerebral venous thrombosis in children: a multifactorial originChristine Heller, Achim Heinecke, Ralf Junker, et al.
European Urology|April 23, 2003
Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?Frank Oberpenning, Stefan Hetzel, Christoph Weining, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2011
Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategyChristian H Brandts, Christiane Schulz, Normann Willich, et al.
Oncology Reports|June 2, 2010
Low SMC1A protein expression predicts poor survival in acute myeloid leukemiaClaudia Hömme, Utz Krug, Nicola Tidow, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2004
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of lifeAndrea Schumacher, Dorothea Riesenbeck, Michael Braunheim, et al.
The Lancet. Neurology|June 15, 2007
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort studyGili Kenet, Fenella Kirkham, Thomas Niederstadt, et al.
British Journal of Haematology|August 6, 2003
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myelomaMartin H Kropff, Nicola Lang, Guido Bisping, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Inflammatory Bowel Diseases|June 15, 2007
Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in lifeBarbara Sonntag, Birgit Stolze, Achim Heinecke, et al.
Thrombosis and Haemostasis|May 12, 2005
Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control studyManuela Krause, Barbara Sonntag, Robert Klamroth, et al.
Circulation|August 27, 2003
Cerebral venous thrombosis in children: a multifactorial originChristine Heller, Achim Heinecke, Ralf Junker, et al.
European Urology|April 23, 2003
Semi-quantitative immunochromatographic test for prostate specific antigen in whole blood: tossing the coin to predict prostate cancer?Frank Oberpenning, Stefan Hetzel, Christoph Weining, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2011
Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategyChristian H Brandts, Christiane Schulz, Normann Willich, et al.
Oncology Reports|June 2, 2010
Low SMC1A protein expression predicts poor survival in acute myeloid leukemiaClaudia Hömme, Utz Krug, Nicola Tidow, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2004
Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of lifeAndrea Schumacher, Dorothea Riesenbeck, Michael Braunheim, et al.
The Lancet. Neurology|June 15, 2007
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort studyGili Kenet, Fenella Kirkham, Thomas Niederstadt, et al.
British Journal of Haematology|August 6, 2003
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myelomaMartin H Kropff, Nicola Lang, Guido Bisping, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Pageof 8